Life & LuxuryArts & CultureAFR MagazinePrint articleNobel Prize winner Peter Doherty reveals his pandemic page-turnersLuke SlatteryMay 22, 2020 – 11.05amSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginPeter Doherty, medical researcher, Nobel prize winner and author, sits down with The Australian Financial Review Magazine for this month’s What I Am Reading column.Our June issue is out on May 29 inside the Financial Review.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleIntroducing your NewsfeedFollow the topics, people and companies that matter to you.Find out moreRead MoreAFR MagazineWhat I Am ReadingLiteratureRevieweBooksScienceNobel PrizeCoronavirus pandemicResearchPeter DohertyLatest In Arts & CultureFetching latest articlesMost Viewed In Life and luxuryThe Australian Financial Review MagazineThe next trend in hotels? Ones you don’t check out ofAnna McCooeThe CEO who rediscovered his love of motorbikes (40 years later)It’s the coolest chalet in Switzerland – though not for everyoneBOSS Financial ReviewThese execs studied offshore MBAs. Here’s what they did nextHannah TattersallThe CEO of this $7b company is doubling his workforce – by using AIHow a banker, coal owner and pokies baron passed the ESG pub testLife & Leisure‘AI agents’ could turn out to be as useless as The Internet Of ThingsJohn DavidsonThe luxury caravan of the future is here – and it’s bulletproofThe designer who made the leggings you probably wearRich ListToorak Rich Listers caught up in mansion fireHannah Wootton‘How very Sydney’: Justin Hemmes forced to unleash charm offensiveBillionaire Geminder mulls asset sales at struggling Pro-Pac business
